News Summary: Thermo Fisher plans $13.6B purchase

Published



THE DEAL: Thermo Fisher Scientific Inc. said Monday that it plans to pay about $13.6 billion, or $76 per share, for Life Technologies Corp.

THE STRATEGY. The deal positions Thermo Fisher to benefit from the expected growth of personalized medicine, which uses genetic analysis to tailor treatments to patients. Analysts also expect the companies to reap savings from the combination and gain leverage in negotiating with suppliers.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.